<DOC>
	<DOCNO>NCT00239018</DOCNO>
	<brief_summary>The objective extension study allow patient treat enteric-coated mycophenolate sodium ( core study CERL080A2405FR01 ) continue treatment assess long-term safety EC-MPS</brief_summary>
	<brief_title>Extension Study Efficacy Safety Enteric-coated Mycophenolate Sodium Administered de Novo Kidney Transplant Patients</brief_title>
	<detailed_description />
	<mesh_term>Mycophenolate mofetil</mesh_term>
	<mesh_term>Mycophenolic Acid</mesh_term>
	<criteria>Inclusion / Exclusion Criteria All patient complete study CERL080A2405FR01 willing continue treatment EntericCoated Mycophenolate Sodium . Other protocoldefined inclusion / exclusion criterion may apply</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>75 Years</maximum_age>
	<verification_date>January 2011</verification_date>
	<keyword>Enteric-Coated Mycophenolate Sodium ( EC-MPS ) , de novo , kidney transplantation , long-term safety .</keyword>
</DOC>